Attached files

file filename
EX-99 - FOUR RIVERS BIOENERGY INC.exhibit991.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549
______________

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  June 30, 2011

FOUR RIVERS BIOENERGY INC.
(Exact Name of Registrant as Specified in Charter)

Nevada

 

000-31091

 

980442163

(State or Other Jurisdiction of Incorporation)

 

(Commission File Number)

 

(IRS Employer

Identification No.)


14 South Molton Street, 3rd Floor

London, United Kingdom

 

W1K 5QP

(Address of Principal Executive Offices)

 

(Zip Code)

  

Registrant’s telephone number, including area code: (44) 1642 674085


Not Applicable
(Former Name or Former Address, if Changed Since Last Report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction .2. below):


¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

 

Information included in this Form 8-K may contain  forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).  This information may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Four Rivers BioEnergy Inc. (“Company”)  to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements.  Forward-looking statements, which involve assumptions and describe the Company’s future plans, strategies and expectations, are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend” or “project” or the negative of these words or other variations on these words or comparable terminology.  These forward-looking statements are based on assumptions that may be incorrect, and there can be no assurance that any projections included in these forward-looking statements will come to pass.  The Company’s actual results could differ materially from those expressed or implied by the forward-looking statements as a result of various factors. Except as required by applicable laws, the Company undertakes no obligation to update publicly any forward-looking statements for any  reason, even if new information becomes available or other events occur in the future.


Item 8.01  Other Events


Attached to this Current Report on Form 8-K, as Exhibit 99.1, is a public presentation about the Company used in conferences and other forums with shareholders, potential investors, analysts and other persons interested in the Company. The information is based on the public reports of the Company previously filed with the Securities and Exchange Commission.


Item 9.01  Financial Statements and Exhibits


Exhibit No.

Description

99.1

Slide Presentation of the Company


 





SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated:   June 27, 2011

FOUR RIVERS BIOENERGY INC.

 

 

 

 

 

 

 

 

 

 

By:

/s/ Martin Thorp

 

 

 

Name: Martin Thorp

 

 

 

Title: Chief Financial Officer